AB
Acorn Bioventures, L.P. disclosed a 5.7% stake in KPTI
Acorn Bioventures, L.P. reported owning 5.7% of Karyopharm Therapeutics Inc. (KPTI) (1,284,221 shares) in a Schedule 13G filed Sep 25, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 25, 2026
- Source
- Schedule 13G